Differences in the Use and Quality of Antidiabetic Therapies in Mexican American and Non-Hispanic Whites With Uncontrolled Type 2 Diabetes in the US: NHANES 2003-2012

Conclusions The quality of antidiabetic therapies of MA and whites with type 2 diabetes who are most uncontrolled need improvement. Intensifying pharmacotherapies among MA may help improve glycemic control disparities. The innovative outcome used in this report may be useful in quality of care studies in the future.

http://tde.sagepub.com/cgi/content/abstract/41/5/582?rss=1

Source: The Diabetes Educator - September 21, 2015 Category: Endocrinology Authors: Perez, A., Elrod, S., Sanchez, J. Tags: Features Source Type: research